Table 3 Analysis of histological, molecular and therapeutic predictors for local recurrence.
| Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
| Relative risk (95% CI) | p Value | Relative risk (95% CI) | p Value | |
| Histology | ||||
| Adenoid cystic carcinoma | 1 | – | 1 | – |
| Adenocarcinoma | 0.635 (0.365 to 1.07) | NS | 0.9 (0.67 to 1.45) | NS |
| Mucoepidermoid/squamous cell carcinoma | 2.1 (1.1 to 4.3) | 0.05 | 1.7 (0.9 to 2.3) | NS |
| TUNEL >6% | 0.7 (0.38 to 1.29) | NS | 1.1 (0.59 to 1.96) | NS |
| Bcl‐2 >6% | 4.0 (1.23 to 11.23) | 0.007 | 2.1 (1.1 to 13.4) | NS |
| p53<10% | 1.2 (0.9 to 1.99) | NS | 1.44 (0.44 to 1.6) | NS |
| Therapy (surgery + radiotherapy) | 1.1 (0.87 to 1.28) | NS | 0.9 (0.67 to 1.6) | NS |